ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
2 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
2.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
2.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
european on.the cards
|
|
Cadyman2017
|
1 |
770 |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1
|
770
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives U.S. FDA clearance for CT LVAS
|
|
Cadyman2017
|
38 |
17K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
38
|
17K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives U.S. FDA clearance for CT LVAS
|
|
Cadyman2017
|
38 |
17K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
38
|
17K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Imbio secures research agreement with US Dept of Vet Affairs
|
|
Cadyman2017
|
26 |
7.2K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
26
|
7.2K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
0 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
2.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2024
|
|
Cadyman2017
|
34 |
11K |
12 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
34
|
11K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Cadyman2017
|
120 |
45K |
3 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
120
|
45K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Cadyman2017
|
763 |
337K |
2 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
763
|
337K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Cadyman2017
|
153 |
48K |
0 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
153
|
48K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Cadyman2017
|
153 |
48K |
6 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
153
|
48K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Cadyman2017
|
153 |
48K |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
153
|
48K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Cadyman2017
|
153 |
48K |
6 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
153
|
48K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Give Us The Good The Bad ,and The Ugly
|
|
Cadyman2017
|
31 |
12K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
31
|
12K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Give Us The Good The Bad ,and The Ugly
|
|
Cadyman2017
|
31 |
12K |
9 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
31
|
12K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Give Us The Good The Bad ,and The Ugly
|
|
Cadyman2017
|
31 |
12K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
31
|
12K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2024
|
|
Cadyman2017
|
22 |
7.7K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
22
|
7.7K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
8 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
4 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
3 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
0 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
1 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
Cadyman2017
|
52 |
16K |
2 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
52
|
16K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Notification regarding unquoted securities - 4DX
|
|
Cadyman2017
|
14 |
4.9K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
14
|
4.9K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
0 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
9 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
4 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
12 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
5 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
5 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Cadyman2017
|
111 |
35K |
1 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
111
|
35K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Cadyman2017
|
763 |
337K |
3 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
763
|
337K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
Cadyman2017
|
78 |
26K |
1 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
78
|
26K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
Cadyman2017
|
78 |
26K |
7 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
78
|
26K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
2 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Dr David Shulkin, MD, joins 4DMedical
|
|
Cadyman2017
|
35 |
13K |
10 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
35
|
13K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
Cadyman2017
|
158 |
69K |
3 |
07/04/23 |
07/04/23 |
ASX - By Stock
|
158
|
69K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
1 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
3 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
1 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2023
|
|
Cadyman2017
|
64 |
23K |
7 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
64
|
23K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
3 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
7 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Appointment of Senior VP Business Development
|
|
Cadyman2017
|
5 |
3.5K |
2 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
5
|
3.5K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
3 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
0 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
1 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Cadyman2017
|
2.5K |
1.0M |
11 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
11
|
|